Benitec Biopharma (BNTC) Consolidated Net Income (2019 - 2025)
Historic Consolidated Net Income for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to -$8.8 million.
- Benitec Biopharma's Consolidated Net Income fell 9010.37% to -$8.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$38.5 million, marking a year-over-year decrease of 7825.91%. This contributed to the annual value of -$38.5 million for FY2025, which is 7825.91% down from last year.
- According to the latest figures from Q2 2025, Benitec Biopharma's Consolidated Net Income is -$8.8 million, which was down 9010.37% from -$14.5 million recorded in Q1 2025.
- In the past 5 years, Benitec Biopharma's Consolidated Net Income registered a high of -$3.5 million during Q1 2022, and its lowest value of -$14.5 million during Q1 2025.
- Its 5-year average for Consolidated Net Income is -$5.8 million, with a median of -$4.8 million in 2021.
- Per our database at Business Quant, Benitec Biopharma's Consolidated Net Income skyrocketed by 1178.57% in 2024 and then plummeted by 25010.86% in 2025.
- Over the past 5 years, Benitec Biopharma's Consolidated Net Income (Quarter) stood at -$4.8 million in 2021, then fell by 15.95% to -$5.6 million in 2022, then fell by 23.38% to -$6.9 million in 2023, then crashed by 43.98% to -$10.0 million in 2024, then increased by 11.86% to -$8.8 million in 2025.
- Its last three reported values are -$8.8 million in Q2 2025, -$14.5 million for Q1 2025, and -$10.0 million during Q4 2024.